Saira Rafaqat

Dr. Saira Rafaqat

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in The Journal of Innovations in Cardiac Rhythm Management
Verified
Journal Article
Open access
SRSaira Rafaqat
Saira Rafaqat
Adipokines and Their Role in Heart Failure: A Literature Review

31 January 2024 in Archives of Medical Science
Verified
Journal Article
Open access
PDF file
SRSaira Rafaqat
Saira Rafaqat
DPDimitrios Patoulias
Dimitrios Patoulias
ABAmir Hossein Behnoush
Amir Hossein Behnoush
SSSaima Sharif
Saima Sharif
AKAleksandra Klisic
Aleksandra Klisic
Acute pancreatitis (AP) is a common inflammatory state characterized by a clinical course that can lead to serious local and extrapancreatic organ malfunction and failure. Interleukins (ILs) are biologically active glycoproteins primarily produced by macrophages and lymphocytes. According to the literature, there are many ILs. However, this article represents a summary of the role of ILs in AP, such as IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12, IL-13, IL-14, IL-15, IL-16, IL-17, IL-18, IL-19, and IL-20. The ways to modulate IL activity to reduce inflammation and improve outcomes in individuals with this condition are under investigation. Drugs that target specific ILs might be developed to mitigate the effects of AP.

30 July 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
RARoha Asif
Roha Asif
AKAmmara Khalid
Ammara Khalid
Tolga MercantepeTolga Mercantepe
Tolga Mercantepe
AKAleksandra Klisic
Aleksandra Klisic
SRSana Rafaqat
Sana Rafaqat
FMFiliz Mercantepe
Filiz Mercantepe
Background: Despite distinct etiologies, type 1 diabetes (T1D) and type 2 diabetes (T2D) share chronic inflammation as a core feature. Interleukins, key immune mediators, play important yet still not fully understood roles in the development and complications of both conditions. Objective: This narrative review aims to provide a comprehensive and critical synthesis of current evidence on the role of key interleukins in T1D and T2D, highlighting their immunological functions, genetic associations, clinical correlations, and translational potential. Methods: A targeted literature search was conducted in PubMed, Google Scholar, and ScienceDirect up to January 2025, focusing on English-language clinical and experimental studies involving interleukins and their relevance to T1D and T2D. Reference lists were manually screened for additional sources. Interleukins (ILs) were reviewed individually to assess their immunobiology, disease specificity, and biomarker or therapeutic value. Findings: Pro-inflammatory cytokines such as IL-1β, IL-6, and IL-17 contribute to islet inflammation, insulin resistance, and microvascular damage in both T1D and T2D. Anti-inflammatory mediators including IL-4, IL-10, and IL-13 exhibit protective effects but vary in expression across disease stages. Less-characterized interleukins such as IL-3, IL-5, IL-9, and IL-27 demonstrate dual or context-dependent roles, particularly in shaping immune tolerance and tissue-specific complications such as nephropathy and neuropathy. Polymorphisms in IL-10 and IL-6 genes further suggest genetic contributions to interleukin dysregulation and metabolic dysfunction. Despite promising insights, translational gaps persist due to overreliance on preclinical models and limited longitudinal clinical data. Conclusions: Interleukins represent a mechanistic bridge linking immune dysregulation to metabolic derangements in both T1D and T2D. While their diagnostic and therapeutic potential is increasingly recognized, future research must address current limitations through isoform-specific targeting, context-aware interventions, and validation in large-scale, human cohorts. A unified interleukin-based framework may ultimately advance personalized strategies for diabetes prevention and treatment.

25 January 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
SRSaira Rafaqat
Saira Rafaqat
SGSanja Gluscevic
Sanja Gluscevic
DPDimitrios Patoulias
Dimitrios Patoulias
SSSaima Sharif
Saima Sharif
AKAleksandra Klisic
Aleksandra Klisic
The existing literature highlights the presence of numerous coagulation factors and markers. Elevated levels of coagulation factors are associated with both existing and newly diagnosed cases of atrial fibrillation (AF). However, this article summarizes the role of coagulation in the pathogenesis of AF, which includes fibrinogen and fibrin, prothrombin, thrombomodulin, soluble urokinase plasminogen activator receptor, von Willebrand factor, P-selectin, D-dimer, plasminogen activator inhibitor-1, and platelet activation. Coagulation irregularities play a significant role in the pathogenesis of AF.

1 December 2022 in Journal of Innovations in Cardiac Rhythm Management
Verified
Journal Article
Open access
SRSaira Rafaqat
Saira Rafaqat
SAShaheed Afzal
Shaheed Afzal
HKHuma Khurshid
Huma Khurshid
SSSanober Safdar
Sanober Safdar
SRSimon Rafaqat
Simon Rafaqat
The Role of Major Inflammatory Biomarkers in the Pathogenesis of Atrial Fibrillation

10 August 2023 in Current Hypertension Reports
Verified
Journal Article
Closed access
PDF file
SRSaira Rafaqat
Saira Rafaqat
AKAmber Khalid
Amber Khalid
SRSaira Riaz
Saira Riaz